Showing results (581-590 of 633) with videos related to

Sort By:
Pageof 64
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 27, 1998
[Detection of apolipoproteins E5 and E7 by a widely used commercial ApoE IFE kit--evidence provided by genotyping]T Imura, H Kimura, S Murata, et al.
Molecular Pharmacology|November 6, 1998
Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks gamma-aminobutyric acid-modulatory activityS M Todorovic, M Prakriya, Y M Nakashima, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|December 18, 2001
Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis systemT Kobayashi, H Makuuchi, K Takahashi, et al.
Endocrine Journal|August 13, 1998
A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research GroupM Shiraki, K Kushida, M Fukunaga, et al.
Clinical Genetics|June 8, 2017
Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrumM Yoshida, M Nakashima, T Okanishi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical studyM Nakashima, T Nakano, Y Ametani, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2006
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trialH Saito, I Maruyama, S Shimazaki, et al.
Clinical Genetics|August 4, 2017
A case of atypical Kabuki syndrome arising from a novel missense variant in HNRNPKN Miyake, M Inaba, S Mizuno, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2018
Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapyT Tada, T Kumada, H Toyoda, et al.
Archives of Virology|September 18, 1998
High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1bK Kanai, M Kako, T Kumada, et al.
Pageof 64